Pfizer-BioNTech was said to have won a contract with the Philippines for the supply of the COVID-19 vaccine. It was reported that the country just signed a deal with the American multinational pharmaceutical and biotechnology company for 40 million doses of the vaccines.
The Philippines and Pfizer deal for coronavirus shots
As per Reuters, this is so far the biggest order of Pfizer COVID-19 vaccine from the Philippines. Secretary Carlito Galvez, the National Task Force chief against coronavirus, announced the deal with Pfizer on Sunday, June 20, and revealed that deliveries could be expected to begin in August.
In addition to this new order from Pfizer-BioNTech, the Philippines has now secured the delivery of 113 million doses of vaccine from five suppliers that include China's Sinovac (26 million doses), Moderna (20 million), Russia's Sputnik V (10 million) and AstraZeneca (17 million).
The vaccine supply in Manila is still limited and in some provinces, the government recorded a surge in COVID-19 cases, which complicates efforts to work up on the immunization drive. But with the upcoming Pfizer supply, officials are hoping that it will reach more people and eventually lessen the cases.
“We are very happy to report that the government and the management of Pfizer have finally concluded our negotiations, Philippine News Agency quoted Galvez as saying. “Health Secretary Francisco Duque and I signed yesterday (Saturday, June 19) the supply agreement for the biggest and most decisive deal we had for 2021.”
More vaccine jabs for the Filipinos
Galvez added that 20 million Filipinos will benefit from this Pfizer COVID-19 supply deal. The Philippines is not just waiting for deliveries from the American biotech company, but it is also expecting deliveries from the COVAX facility. In addition, a total of 16 million doses are coming from Jonhson & Johnson and Novavax as well.
Meanwhile, the Philippines will be allowing the administration of the Pfizer-BioNTech vaccines to youngsters ages 12 to 15. Their inoculation may begin later this year once the vaccine inventory expands and the priority group’s vaccinations are completed.


Asian Currencies Slide as Oil Prices Surge Amid U.S.-Israel-Iran Conflict
Oil Prices Hold Steady Amid Middle East Escalation and Sanctions Relief
Goldman Sachs Delays Bank of England Rate Cut Forecast Amid Middle East Inflation Risks
U.S. Stock Futures Slide as Iran Conflict and Inflation Fears Rattle Wall Street
Virgin Australia Adjusts Fares Amid Rising Aviation Costs and Middle East Tensions
Asian Markets Mixed as Oil Volatility and Inflation Fears Weigh on Sentiment
Gold Prices Extend Losing Streak, On Track for Worst Weekly Loss Since 1983
Global Markets Tumble as US-Iran Tensions Escalate, Oil Surges
Trump Signals End of U.S. Military Campaign Against Iran as Markets Rally
U.S. Appeals Court Strikes Down FTC Order Against TurboTax "Free" Advertising
Goldman Sachs Raises Oil Price Forecasts Amid Strait of Hormuz Disruptions
Sonova Shares Slip as Hearing Aid Giant Lowers Growth Outlook and Plans Sennheiser Exit
Trump Issues 48-Hour Ultimatum to Iran Over Strait of Hormuz, Threatens Power Grid Strikes
Asian Currencies Slide as U.S.-Iran Tensions and Rising Oil Prices Rattle Markets
Goldman Sachs Raises ECB Rate Hike Forecast Amid Persistent Energy-Driven Inflation
SLMG Beverages Eyes Price Hikes Amid Rising Packaging Costs and India's Booming Soft Drink Market
GE Vernova and Hitachi's $40 Billion SMR Investment Signals a New Era for U.S. Nuclear Energy 



